182 related articles for article (PubMed ID: 37871298)
41. The interactions between gut microbiota and bioactive ingredients of traditional Chinese medicines: A review.
Gong X; Li X; Bo A; Shi RY; Li QY; Lei LJ; Zhang L; Li MH
Pharmacol Res; 2020 Jul; 157():104824. PubMed ID: 32344049
[TBL] [Abstract][Full Text] [Related]
42. Dietary polyphenol impact on gut health and microbiota.
Wan MLY; Co VA; El-Nezami H
Crit Rev Food Sci Nutr; 2021; 61(4):690-711. PubMed ID: 32208932
[TBL] [Abstract][Full Text] [Related]
43. A Comprehensive Review on Biotransformation, Interaction, and Health of Gut Microbiota and Bioactive Components.
Zhang L; Ma XG
Comb Chem High Throughput Screen; 2024; 27(11):1551-1565. PubMed ID: 37916626
[TBL] [Abstract][Full Text] [Related]
44. Food Chemicals Disrupt Human Gut Microbiota Activity And Impact Intestinal Homeostasis As Revealed By In Vitro Systems.
Defois C; Ratel J; Garrait G; Denis S; Le Goff O; Talvas J; Mosoni P; Engel E; Peyret P
Sci Rep; 2018 Jul; 8(1):11006. PubMed ID: 30030472
[TBL] [Abstract][Full Text] [Related]
45. Quantification of Panax notoginseng saponins metabolites in rat plasma with in vivo gut microbiota-mediated biotransformation by HPLC-MS/MS.
Guo YP; Chen MY; Shao L; Zhang W; Rao T; Zhou HH; Huang WH
Chin J Nat Med; 2019 Mar; 17(3):231-240. PubMed ID: 30910060
[TBL] [Abstract][Full Text] [Related]
46. Metabolic fate of environmental chemical triclocarban in colon tissues: roles of gut microbiota involved.
Wang G; Zhang H; Zhang J; Sanidad KZ; Yeliseyev V; Parsonnet J; Haggerty TD; Yang H; Ai L; Xie M; Cai Z; Zhang G
Sci Total Environ; 2021 Sep; 787():147677. PubMed ID: 34004538
[TBL] [Abstract][Full Text] [Related]
47. BioTransformer 3.0-a web server for accurately predicting metabolic transformation products.
Wishart DS; Tian S; Allen D; Oler E; Peters H; Lui VW; Gautam V; Djoumbou-Feunang Y; Greiner R; Metz TO
Nucleic Acids Res; 2022 Jul; 50(W1):W115-W123. PubMed ID: 35536252
[TBL] [Abstract][Full Text] [Related]
48. Metatox - Web application for generation of metabolic pathways and toxicity estimation.
Rudik A; Bezhentsev V; Dmitriev A; Lagunin A; Filimonov D; Poroikov V
J Bioinform Comput Biol; 2019 Feb; 17(1):1940001. PubMed ID: 30866738
[TBL] [Abstract][Full Text] [Related]
49. MetaTox: Web Application for Predicting Structure and Toxicity of Xenobiotics' Metabolites.
Rudik AV; Bezhentsev VM; Dmitriev AV; Druzhilovskiy DS; Lagunin AA; Filimonov DA; Poroikov VV
J Chem Inf Model; 2017 Apr; 57(4):638-642. PubMed ID: 28345905
[TBL] [Abstract][Full Text] [Related]
50. Predicting drug-metagenome interactions: Variation in the microbial β-glucuronidase level in the human gut metagenomes.
Elmassry MM; Kim S; Busby B
PLoS One; 2021; 16(1):e0244876. PubMed ID: 33411719
[TBL] [Abstract][Full Text] [Related]
51. Costs of molecular adaptation to the chemical exposome: a focus on xenobiotic metabolism pathways.
Tomkiewicz C; Coumoul X; Nioche P; Barouki R; Blanc EB
Philos Trans R Soc Lond B Biol Sci; 2024 Mar; 379(1898):20220510. PubMed ID: 38310928
[TBL] [Abstract][Full Text] [Related]
52. Tiliae flos metabolites and their beneficial influence on human gut microbiota biodiversity ex vivo.
Kruk A; Granica S; Popowski D; Malinowska N; Piwowarski JP
J Ethnopharmacol; 2022 Aug; 294():115355. PubMed ID: 35537603
[TBL] [Abstract][Full Text] [Related]
53. Effects of Gut Microbiota on Drug Metabolism and Guidance for Rational Drug Use Under Hypoxic Conditions at High Altitudes.
Zhang J; Zhang J; Wang R; Jia Z
Curr Drug Metab; 2019; 20(2):155-165. PubMed ID: 30338735
[TBL] [Abstract][Full Text] [Related]
54. The effect of gut microbiota on drug metabolism.
Kang MJ; Kim HG; Kim JS; Oh DG; Um YJ; Seo CS; Han JW; Cho HJ; Kim GH; Jeong TC; Jeong HG
Expert Opin Drug Metab Toxicol; 2013 Oct; 9(10):1295-308. PubMed ID: 24033282
[TBL] [Abstract][Full Text] [Related]
55. Kansuiphorin C and Kansuinin A ameliorate malignant ascites by modulating gut microbiota and related metabolic functions.
Zhang Y; Lou JW; Kang A; Zhang Q; Zhou SK; Bao BH; Cao YD; Yao WF; Tang YP; Zhang L
J Ethnopharmacol; 2020 Mar; 249():112423. PubMed ID: 31765764
[TBL] [Abstract][Full Text] [Related]
56. Gut microbiota in healthy and unhealthy long-living people.
Zhang S; Zeng B; Chen Y; Yang M; Kong F; Wei L; Li F; Zhao J; Li Y
Gene; 2021 May; 779():145510. PubMed ID: 33600956
[TBL] [Abstract][Full Text] [Related]
57. Chemical reaction vector embeddings: towards predicting drug metabolism in the human gut microbiome.
Mallory EK; Acharya A; Rensi SE; Turnbaugh PJ; Bright RA; Altman RB
Pac Symp Biocomput; 2018; 23():56-67. PubMed ID: 29218869
[TBL] [Abstract][Full Text] [Related]
58. SOMP: web server for in silico prediction of sites of metabolism for drug-like compounds.
Rudik A; Dmitriev A; Lagunin A; Filimonov D; Poroikov V
Bioinformatics; 2015 Jun; 31(12):2046-8. PubMed ID: 25777527
[TBL] [Abstract][Full Text] [Related]
59. Metage2Metabo, microbiota-scale metabolic complementarity for the identification of key species.
Belcour A; Frioux C; Aite M; Bretaudeau A; Hildebrand F; Siegel A
Elife; 2020 Dec; 9():. PubMed ID: 33372654
[TBL] [Abstract][Full Text] [Related]
60. MetaPASS: A Web Application for Analyzing the Biological Activity Spectrum of Organic Compounds Taking into Account their Biotransformation.
Rudik A; Dmitriev A; Lagunin A; Filimonov D; Poroikov V
Mol Inform; 2021 Apr; 40(4):e2000231. PubMed ID: 33191610
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
